Cyclosporin in chronic urticaria: State of the art;Ciclosporina nell'orticaria cronica: Stato dell'arte

Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale

Volumn 61, Issue 1, 2007, Pages 6-11

  Cassano, Nicoletta ^a   Cesare, Giulia ^a   Tsapoga, Vasiliki ^a   Vena, Gino Antonio ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Autoimmunity; Chronic urticaria; Cyclosporin A; Mechanism of action; Treatment

Indexed keywords

CYCLOSPORIN A; HISTAMINE H1 RECEPTOR ANTAGONIST; PLACEBO;

ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; BASOPHIL; CHRONIC URTICARIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; HUMAN; IMMUNOMODULATION; MAST CELL; MICROEMULSION; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 34250736221     PISSN: 15926826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Burrall BA, Halpern GM, Huntley AC. Chronic urticaria. West J Med 1990; 152: 268.
2. Pigatto PD, Valsecchi RH. Chronic urticaria: a mystery. Allergy 2000; 55: 306.
3. Beltrani VS. An overview of chronic urticaria. Clin Rev Allergy Immunol 2002; 23: 147.
4. Tosoni C, Cinquini M. Diagnostic and therapeutic iter in chronic urticaria patients. Int J Immunopathol Pharmacol 2006; 19: 265.
5. Zuberbier T, Bindslev-Jensen C, Canonica W, et al. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006; 61: 316.
6. Zuberbier T, Bindslev-Jensen C, Canonica W, et al. EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy 2006; 61: 321.
7. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004; 114: 465.
8. Sabroe RA, Greaves MW. Chronic idiopathic urticaria with functional autoantibodies: 12 years on. Br J Dermatol 2006; 154: 813.
9. Maurer M, Metz M, Magerl M, et al. Autoreaktive Urtikaria und Autoimmunurtikaria. Hautarzt 2004; 55: 350.
10. Guttman-Yassky E, Bergman R, Maor C, et al. The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals. J Eur Acad Dermatol Venereol 2007; 21: 35.
11. Sabroe RA, Francis DM, Barr RM, et al. Anti-FcεRI autoantibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 1998; 102: 651.
12. Sabroe RA, Seed PT, Francis DM, et al. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcεRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999; 40: 443.
13. Cassano N, Galeazzi M, De Pità O, et al. Sindrome orticaria-angioedema, autoimmunità e malattie del connettivo. Progr Reumatol 2002; 3: 312.
14. Griffiths CE, Katsambas A, Dijkmans BA, et al. Update on the use of cyclosporin in immune-mediated dermatoses. Br J Dermatol 2006; 155 (Suppl 2): 1.
15. Matsuda S, Koyasu S. Regulation of MAPK signaling pathways through immunophilin-ligand complex. Curr Top Med Chem 2003; 3: 1358.
16. Pessler F, Dai L, Cron RQ, et al. NFAT transcription factors: new players in the pathogenesis of inflammatory arthropathies? Autoimmun Rev 2006; 5: 106.
17. Pedersen C, Permin H, Stahl Skov P, et al. Inhibitory effect of cyclosporin A on histamine release from human leukocytes and rat mast cells. Allergy 1985; 40: 103.
18. Cirillo R, de Paulis A, Ciccarelli A, et al. Cyclosporin A inhibits mediator release from human Fc epsilon RI+ cells by interacting with cyclophilin. Int Arch Allergy Appl Immunol 1991; 94: 76.
19. Hatfield SM, Roehm NW. Cyclosporine and FK506 inhibition of murine mast cell cytokine production. J Pharmacol Exp Ther 1992; 260: 680.
20. Toyota N, Hashimoto Y, Matsuo S, et al. Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells. Arch Dermatol Res 1996; 288: 474.
21. Toyoda M, Morohashi M. Morphological assessment of the effects of cyclosporin A on mast cell-nerve relationship in atopic dermatitis. Acta Derm Venereol 1998; 78: 321.
22. Plath KE, Grabbe J, Gibbs BF. Calcineurin antagonists differentially affect mediator secretion, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases from immunologically activated human basophils. Clin Exp Allergy 2003; 33: 342.
23. Harrison CA, Bastan R, Peirce MJ, et al. Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506. Br J Pharmacol 2007 (in stampa).
24. Marsland AM, Soundararajan S, Joseph K, et al. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy 2005; 35: 554.
25. Frezzolini A, Provini A, Teofoli P, et al. Serum-induced basophil CD63 expression by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urticaria. Allergy 2006; 61: 1071.
26. Grattan CE, O'Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 2000; 143: 365.
27. Khan LN, Kon OM, Macfarlane AJ, et al. Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin. Am J Respir Crit Care Med 2000; 162: 1377.
28. Spisani S, Fabbri E, Muccinelli M, et al. Inhibition of neutrophil responses by cyclosporin A: an insight into molecular mechanisms. Rheumatology 2001; 40: 794.
29. Markovic S, Raab M, Daxecker H, et al. In vitro effects of cyclosporin A on the expression of adhesion molecules on human umbilical vein endothelial cells. Clin Chim Acta 2002; 316: 25.
30. Vena GA, Cassano N, Mastrolonardo M. The mechanism of action of cyclosporin A in the treatment of chronic urticaria. Sem Clin Immunol 1997; 13: 21.
31. Fradin MS, Ellis CN, Goldfarb MT, et al. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol 1991; 25: 1065.
32. Barlow RJ, Kobza Black A, Greaves MW. Treatment of severe chronic urticaria with cyclosporin A. Eur J Dermatol 1993; 3: 273.
33. Vena GA, Curatoli G, Fiordalisi F, et al. La ciclosporina A nel trattamento dell'orticaria cronica idiopatica severa: studio clinico su otto casi. Boll Dermatol Allergol Profess 1993; 8: 309.
34. Curatoli G, D'Argento V, Fiordalisi F, et al. Trattamento dell'orticaria cronica: chetotifene versus cetirizina in schema sequenziale con ciclosporina A. Boll Dermatol Allergol Profess 1996; 11: 113.
35. Toubi E, Blant A, Kessel A, et al. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 1997; 52: 312.
36. Ilter N, Gurer MA, Akkoca MA. Short-term oral cyclosporine for chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 1999; 12: 67.
37. Loria MP, Dambra PP, D'Oronzio L, et al. Cyclosporin A in patients affected by chronic idiopathic urticaria: a therapeutic alternative. Immunopharmacol Immunotoxicol 2001; 23: 205.
38. Di Gioacchino M, Di Stefano F, Cavallucci E, et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc 2003; 24: 285.
39. Baskan EB, Tunali S, Turker T, et al. Comparison of short-and long-term cyclosporine A therapy in chronic idiopathic urticaria. J Dermatolog Treat 2004; 15: 164.
40. Cassano N, D'Argento V, Vena GA. Cyclosporin A in chronic idiopathic urticaria: an update. Int J Immunopathol Pharmacol 2002; 15 (Suppl. Jan-Apr): 13.
41. Vena GA, Cassano N, Colombo D, et al. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 2006; 55: 705.
42. Toubi E, Bamberger E, Kessel A. Prolonged cyclosporin-A treatment for severe chronic urticaria. Allergy 2003; 58: 535.
43. Kessel A, Toubi E. Extended cyclosporine-A-treatment for severe chronic urticaria. Harefuah 2006; 145: 411.